Quantum Biology DAO
QBIO
Evaluation Score
Overall rating on a scale of 0-10
Dimension Breakdown
AI Analysis
Comprehensive evaluation of the token
Quantum Biology DAO (QBIO) is a micro-cap decentralized science (DeSci) token under the BIO Protocol umbrella supporting early-stage quantum biology research through grants. On the positive side, the project features a public and credentialed founding team (Geoff Anders and Clarice D. Aiello) structured as a 501(c)(3) non-profit affiliated with the bio.xyz accelerator. However, QBIO suffers from substantial foundational risks across multiple categories. In active development and community engagement, it shows minimal public code artifacts, no published audits, and a very small community footprint (~570 on-chain holders). Economically, the token faces conflicting total/circulating supply figures across tracking platforms, heavy dilution overhang, and negligible market liquidity (~$520K market cap). Crucially, automated security analysis (GoPlus) flags the smart contract as 'Risky' due to centralized owner privileges allowing contract alterations, minting, and transfer modifications, posing significant holder risk in the absence of a professional third-party audit.
Development Activity
Code updates and developer engagement
Community Support
Social media presence and community engagement
Tokenomics
Supply, distribution, and utility
Market & Use Case
Value proposition and competitive landscape
Team & Governance
Team background and project governance
Security & Audits
Security history and audit status
About Quantum Biology DAO (QBIO)
Quantum Biology DAO (QBIO) is a decentralized science (DeSci) project operating primarily on the Ethereum blockchain, with reported presence on Solana, under the BIO Protocol umbrella. Structured as a 501(c)(3) California non-profit and accepted into the bio.xyz accelerator cohort, the project was co-founded by Geoff Anders and Clarice D. Aiello. Its core purpose is to fund early-stage quantum biology research, scientific experimentation, and intellectual property development through decentralized grants and community governance. The QBIO token functions as an ERC-20 utility and governance asset supporting staking, ecosystem participation, and proposal voting.
The project maintains an active decentralized organization setup with recurring grant updates and governance proposals, though its on-chain footprint remains small, with approximately 570 token holders and limited transaction volume. Discrepancies exist regarding its tokenomic data across public trackers, with CoinGecko reporting a maximum supply of 1 billion tokens and roughly 190 million circulating, while other venues report different totals. Formal allocation breakdowns, unlock timelines, and vesting schedules are not publicly documented.
QBIO is subject to significant market and technical risks. The token has experienced a severe price drawdown, trading roughly 85% to 90% below its all-time high alongside negligible liquidity depth. In terms of security, the project has no completed third-party smart contract audits by recognized security firms, and public software repositories remain minimal. Additionally, automated security scans by GoPlus classify the smart contract as risky due to privileged contract-creator controls that allow for parameter changes, fee adjustments, minting, and potential restrictions on transfers.